Floatz logo

cd146/her2 car-t cells

Sarcoma of Bone

Essen BiotechCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Sarcoma of Bone cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Essen Biotech
Phase 2BB
Fludarabine
Essen Biotech
Phase 2B
Nivolumab
M.D. Anderson Cancer Center
Phase 2CCC
TEONANACATL
University Health Network, Toronto
Phase 2CCC
Ipilimumab
M.D. Anderson Cancer Center
Phase 2CCC

View all 12 →

Same molecule, other indications

cd146/her2 car-t cells is also rated in:

Kaposi's sarcomaDormant
CCC
Indicative ·
48 / 100
View asset →
Ewing sarcomaDormant
CCC
Indicative ·
48 / 100
View asset →
soft tissue sarcomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →